2A97 Alpdogan, Seyfettin Onder - Thomas Jefferson University - Thomas Jefferson University
Dr. Alpdogan

S. Onder Alpdogan, MD

Contact Dr. Alpdogan

925 Chestnut Street
Suite 320A
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. Amlodipine-induced hypersensitivity reaction mimicking CD30+ mycosis fungoides
  2. Bullous leukemia cutis in a patient with T-cell prolymphocytic leukemia
  3. A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation
  4. A two-step approach to myeloablative haploidentical transplantation: Low nonrelapse mortality and high survival confirmed in patients with earlier stage disease
  5. Hematopoietic stem cell transplantation for primary cutaneous γδ T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma
  6. Kaposi sarcoma mimicking multiple cherry angiomata clinically and histologically in a patient with sezary syndrome: An unusual presentation
  7. Advances in immune regulation in transplantation
  8. Interleukin-15 administration increases graft-versus-tumor activity in recipients of haploidentical hematopoietic SCT
  9. Haploidentical hematopoietic SCT increases graft-versus-tumor effect against renal cell carcinoma
  10. Recent advances in haploidentical stem cell transplantation
  11. Immune tolerance and transplantation
  12. Double Haploidentical Hematopoietic Stem Cell Transplantation Results in Successful Engraftment of Bone Marrow from Both Donors without Graft-versus-Host or Graft-versus-Graft Effects
  13. Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation
  14. Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host disease
  15. Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation
  16. STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease
  17. Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation
  18. Organ-derived dendritic cells have differential effects on alloreactive T cells
  19. IFN-γ and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease
  20. Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity